SCHEMBL31694509

SCHEMBL31694509

N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.73
▸ CXCR4 P61073 8/20 0.63
▸ CTSL P07711 2/20 0.60
▸ CTSS P25774 2/20 0.60
▸ CTSK P43235 2/20 0.60
▸ GLP1R P43220 4/20 0.60
▸ GCGR P47871 4/20 0.60
▸ CTSH P09668 1/20 0.59
▸ GIPR P48546 1/20 0.58
▸ MC4R P32245 1/20 0.58
▸ MC5R P33032 1/20 0.58
▸ MC3R P41968 1/20 0.58
▸ MC1R Q01726 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31694510 0.96 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL30518946 0.92 C5AR1 (0.69) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL30518949 0.92 C5AR1 (0.69) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29655769 0.92 C5AR1 (0.69) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29794089 0.92 C5AR1 (0.69) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29793977 0.91 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29655807 0.91 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29389916 0.91 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29655671 0.91 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK
SCHEMBL29794073 0.91 C5AR1 (0.68) C5AR1CXCR4CTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50618-E1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same PHARMAIN CORPORATION (US) 2025-10-07 — — US disclosed
Send feedback